acquired
Stage
1
Investors
About
TiGenix is a biotechnology company developing and commercializing allogeneic cell therapies focused on inflammatory diseases. Their lead product candidates utilize stem cell technology to treat conditions such as Crohn's disease.
Explore TiGenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.